• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

VNA or PACS-centric Models Lead Enterprise Imaging Plans

Article

Most healthcare providers developing an enterprise imaging strategy are considering a vendor-neutral archive or a PACS enterprise archive solution, KLAS found.

Most healthcare providers developing an enterprise imaging strategy are considering a vendor-neutral archive or a PACS enterprise archive solution, according to a new KLAS report.

The report, Enterprise Imaging 2012: Provider’s Strategies and Insights, found that most providers are in the early stages of forming the strategy that would allow access to images at the right time and place, according to market research firm KLAS.

"Image storage is a necessity, no matter what option is chosen," said Ben Brown, imaging research director and author of the report. "As providers start to bring in more studies and the studies themselves increase in size, the need for storage will increase. In addition, as a provider explained, images will need to be managed as well as stored."

Of the providers interviewed, 27 percent said that a vendor-neutral archive (VNA) would be central to their strategy. This option was selected most often by hospitals with more than 500 beds. A PACS-centric archive solution was selected by 25 percent of providers, most of them facilities with fewer than 500 beds.

GE and Philips were mentioned most often by those interviewed, and customers said they considered their vendor to be part of the imaging strategy moving forward, particularly for a PACS-centric approach. Fuji also has a strong PACS enterprise archive offering, according to KLAS. Agfa and Merge were most often cited for VNA approaches.

Provider Reported Enterprise Imaging Strategy:


 chart credit: KLAS

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.